Velux Stiftung Assistant Professor for
Systems and Cell Biology of Neurodegeneration
Division of Psychiatry Research
University of Zurich
August-Forel Str. 1
Tel. +41 44 634 8860
The Systems and Cell Biology of Neurodegeneration Lab, at the Department of Psychiatry Research, studies the molecular and cellular basis of neurodegenerative diseases.
Alzheimer’s disease, membrane trafficking, endocytosis, amyloid, systems biology
1 Professor, 1 Lab Manager, 4 PhD Students, 1 Postdoc
Systems Biology: In this part, we investigate the etiology of Alzheimer Disease. There are thousands of coding and non-coding genes in the human genome. How do these contribute to the pathogenesis? Neurodegenerative diseases are complex whose etiologies cannot be pinned to a few genes. Particularly, in the case of late onset Alzheimer’s disease (AD) that comprises more than 95% of the AD population, the identity of the risk genes is still not known. By combining functional genomics with computational tools, we intend to understand the complex molecular network that underlies AD. We used state of the art high-throughput screening methods to identify genes involved in Alzheimer’s disease and by performing network analysis on the identified genes, we have zeroed in on certain key regulators. Further characterization in vitro and in vivo revealed novel insights into the pathology. We are now investigating the molecular mechanisms of the other hits that were identified by this screen.
Cell Biology: On the cell biology aspect, our lab investigates the possible physiological roles of proteins involved in the onset of Alzheimer’s disease. We address an important question relating to the disease: Is Alzheimer’s disease a physiological process gone awry? We study the role of membrane trafficking and subcellular compartmentalization in amyloid plaque formation and synaptic dysfunction observed in Alzheimer’s disease.
Our goal is to understand the molecular complexity underlying Alzheimer’s disease. Not only do we intend to draw a “parts list” identifying components but also in parallel, characterize the mechanism by which these components regulate this process. Such systems biology approaches would not only advance our understanding of the disease but also would aid in the development of therapeutics and diagnostics and in providing biomarkers for personalized medicine. We are now extending our screening approaches to various other neurodegenerative diseases to find the commonality and specificity in these diseases.
Our investigations into the cell biology of the disease would help curate a roadmap wherein the relevant players of the disease are placed in a cellular context. Does the disease pathway hijack existing cellular machinery for its pathogenesis or is the disease a physiological process gone awry? How does aging affect membrane trafficking, lipid homeostasis, cellular signaling that could potentiate the onset of the disease? By understanding the cell biology of the disease, could we identify better biomarkers or design better inhibitors? Our projects are aimed at addressing these questions.
Cell biology techniques (immunostaining, endocytosis, pulse-chase, preparation of exosomes, lipid rafts, subcellular trafficking, targeting, BAC technology, RNAi (si and esiRNAs, protease assays, standard biochemistry, molecular and cell biology techniques, etc)
Screening approaches include use of RNAi screens, small molecule compound screens, computational network analysis, medium to highthroughput liquid handling and assay systems, etc)
Velux Stiftung, NCCR Neural Plasticity and Repair, Alzheimer Research Initiative, Hans- & Ilse Breuer Stiftung, SNF.
Diese Website wird in älteren Versionen von Netscape ohne graphische Elemente dargestellt. Die Funktionalität der Website ist aber trotzdem gewährleistet. Wenn Sie diese Website regelmässig benutzen, empfehlen wir Ihnen, auf Ihrem Computer einen aktuellen Browser zu installieren. Weitere Informationen finden Sie auf
The content in this site is accessible to any browser or Internet device, however, some graphics will display correctly only in the newer versions of Netscape. To get the most out of our site we suggest you upgrade to a newer browser.